National Veterinary Services has launched NVS Webshop, an online veterinary shop that practices can bolt on to their own website, or setup as a standalone online shop.
NVS says the shop, which is branded with your practice livery, includes the following features:
For more information visit: http://www.vet2pet.co.uk, email: salesandmarketing@nvs-ltd.co.uk or call 01782 770326.
YourVets, the network of privately owned small animal veterinary practices has opened a new clinic in Dagenham, Essex and is re-opening an expanded and improved practice in Wythall, Birmingham later this month.
YourVets already has five clinics operating throughout the West Midlands and Essex, with the philosophy of providing a friendly, caring and high-quality service at an affordable price.
YourVets says its Dagenham clinic is a new, purpose-built facility while the Wythall premises has been enlarged and improved to supersede the old Pet Vaccination Clinic. The Wythall clinic has also been re-branded under the YourVets name, to reflect that fact that its veterinary care has grown to encompass the full range of veterinary procedures, rather than just vaccinations.
The clinics are equipped with high-tech equipment and top-class facilities. They offer a walk in appointment service to provide clients with maximum convenience and flexibility and have easy access to YourVets' own affordable 24-hour emergency service. Owners can also register their pets and order prescriptions online, for added speed and efficiency.
Jonathan Stirling, Managing Director of the PVC/YourVets group, said: "At Dagenham and Wythall, as with all our clinics, visitors and staff will be able to benefit from outstanding facilities, including air conditioned buildings, easy parking and the very latest medical equipment in a relaxed, fun and welcoming atmosphere."
Faye Fraser, Practice Manager at the YourVets Coventry clinic, says: "I love my role at YourVets. It gives me immense satisfaction to know that so many pets and owners have access to our truly affordable prices and professional veterinary service. We all care deeply about the animals we treat, and my love for animals extends into my home life, too. I have two rescue cats Tarot and Sorrell, who both need lifelong medical care."
YourVets currently has clinics at Coventry and Nuneaton in the West Midlands and Rayleigh in Essex. YourVets Dagenham opened on 4th February 2012 and the new-look YourVets Wythall will launch on 12th February 2012, with a special open day.
For more information about YourVetsvisit http://www.yourvets.co.uk/.
Petplan has been named the UK's Best Pet Insurance Provider at the Consumer Moneyfacts awards.
Voted for by over 17,000 consumers, the awards recognise the best financial products available to consumers in the UK.
Petplan, which says it has recently strengthened its policies to provide pet owners with more comprehensive cover, was chosen by consumers for its market leading policies and outstanding customer service.
Petplan Director Neil Brettell said: "The award is great recognition for the fantastic job that our team at Petplan does to keep pets healthy and owners happy.
"Our Covered for Life policies truly do what they say, they ensure that a pet can get the best possible treatment throughout its life without the owner having to worry about the cost. It's great to be recognised for the service that we've been providing to the nation's pets for over 35 years."
For information about how working with Petplan can help your practice call Vetline on 0800 316 8800 or visit www.petplanvet.co.uk
Vetoquinol UK Ltd has launched a new flea and tick treatment for cats and dogs.
Flevox is a spot-on solution containing fipronil and comes in unique pack sizes of either single pipettes or large clinic packs of 36.
Product Manager Helen Walker said: "With only 55% of pet owners buying their flea and tick treatment from the vet, we recognise there is a huge opportunity to develop and grow this essential market. In the modern age the consumer expects maximum flexibility, and that is what we aim to provide with Flevox.
Whether it be persuading the price-conscious customer away from buying their flea treatments in supermarkets and the internet, or encouraging those who don't treat their pet at all to give it a try without breaking the bank, we're confident we can help grow flea treatment sales in practice."
Vetoquinol says it is supporting the new product with a range of materials dedicated to veterinary surgeries, providing incentives to encourage client bonding and repeat business with your practice.
Helen continued: "We have also teamed up with the fantastic charity Dogs for the Disabled by making a donation for every pipette of Flevox sold. We're really looking forward to raising the profile of this organisation where these amazing dogs give life changing independence to disabled people. We're confident the donation will strike a chord with clients and really engage them with the charity, the Flevox brand and the practice".
To find out more, contact your Vetoquinol territory manager or visit http://www.vetoquinol.co.uk/
Davies Veterinary Specialists has announced that it will be launching a new referral service in the heart of London at an event being held at the Institute of Physics at 7:00pm on 15th February.
As part of the preparations, the multi-discipline referral centre has published a very polished video which you can view here.
The launch event includes some free CPD: "Challenges in Urology", together with drinks and nibbles.
Vetoquinol has launched Myo Power, the latest addition to the Equistro Performance range of nutritional supplements.
The company says that Myo Power has been formulated with the performance and convalescent horse in mind, and that it is an excellent source of easily digestible protein enriched with L-Leucine and other key essential amino acids necessary for optimal muscular cell development, specifically via the mitochondria.
Vetoquinol claims the product is extremely beneficial for young horses being prepared for sales, competition horses in training, and the convalescent or older horse following periods of box rest or restricted exercise.
Myo Power is available in 1.2kg and 2.3kg tubs. For further information, please contact your local Vétoquinol Territory Manager.
Following legislative changes, the British Veterinary Association has updated its 'Good Practice Guide to Handling Veterinary Waste' for England and Wales.
Supported by the Environment Agency the Guide primarily consists of a quick-reference poster enabling vets to categorise and segregate veterinary waste in line with Environment Agency requirements. The poster defines the types of hazardous waste, outlines the types of containers required and sets out the appropriate classification codes.
The Guide is complemented by more detailed web guidance which incorporates useful templates to download.
BVA President Carl Padgett said: "All businesses have a duty of care to ensure that all waste is stored and disposed of responsibly, that it is only handled or dealt with by those authorised to do so and that appropriate records are kept of all waste that is transferred or received.
"The BVA Guide has been a popular resource for the profession since we first launched it in 2008 making it considerably easier for vets to comply with Hazardous Waste Regulations. The revised poster is hopefully an incentive for practices to check if their requirements have changed and ensure they're still up-to-date."
The poster and web advice are available at http://www.bva.co.uk/activity_and_advice/1641.aspx and BVA members will receive a hard copy of the poster to display in their practice.
In case you missed the email last month, Novartis Animal Health has announced the launch of Atopica for Cats (cyclosporine oral solution, 100 mg/ml), a treatment for chronic allergic dermatitis.
This disease, which is apparently one of the most common reasons for pet owners to take cats to the veterinary surgeon2, can be difficult to diagnose and causes itching and associated chewing and licking, skin lesions and loss of hair. Atopica for Cats is the first medication approved in the UK specifically for allergic dermatitis in cats.
Novartis says the new product provides relief from the uncomfortable and recurrent itch/scratch cycle, and the majority of improvements are seen in the first four weeks3-5. The company also says that in clinical trials, 84 per cent of cats diagnosed with allergic dermatitis were considered to be "uncomfortable" at the start of the study5. After six weeks of treatment with Atopica for Cats, 78 per cent of cats were considered "comfortable" with satisfactory levels of grooming3 - a key indicator of a healthy cat. Additionally, Atopica for Cats is proven to significantly reduce unsightly and painful skin lesions and has a proven safety profile.
Anne-Laure Driscoll, Atopica Brand Manager, Novartis Animal Health UK, said: "Veterinarians and pet owners understand the discomfort and frustration of an itchy pet. We are pleased to add Atopica for Cats to our proven family of Atopica products, offering an effective treatment for cats suffering from the extreme discomfort associated with allergic dermatitis."
Developed specifically for domestic felines, Atopica for Cats is an oral solution which Novartis says is easy-to-dose and administer. In studies, approximately one-third of cats took the medicine in their food and two-thirds were dosed directly into the mouth3,4. According to the company, the product offers a unique mode of action that specifically targets immune cells such as the T-lymphocytes involved in the allergic reaction. In this way, Atopica for Cats blocks the production of inflammatory cytokines, molecules that fuel the allergic response, breaking the recurrent itch/scratch cycle.
Dr. Keith Hnilica, DVM, MS, MBA and DACVD, and author of Small Animal Dermatology: A Color Atlas and Therapeutic Guide (3rd ed), said: "Atopica for Cats has the potential to change how our profession treats the itchy cat. For the first time ever, we have a safe, highly effective, approved treatment for cats with allergic dermatitis. And because Atopica for Cats is not a corticosteroid, I can prescribe it for long-term use without worrying about the health risks that can be associated with steroids."
References
The Veterinary Benevolent Fund has launched a short film about a veterinary surgeon's experience of severe depression and her inspiring recovery.
The charity says it hopes the film, published on the Vetlife website today, will encourage the veterinary profession to talk more openly about stress and depression in the workplace and will motivate veterinary employers to adopt best practice in supporting their staff's mental health.
Nick Short, the VBF Director responsible for the development of the Vetlife website, said: "We are so grateful to the veterinary surgeon concerned for having the courage to share her story and for her insights into what could be done to make recovery easier for other vets. We were delighted to hear that she felt she was treated well and got the help she needed from the Veterinary Benevolent Fund and the Veterinary Surgeons' Health Support Programme.
"Recent press reports have estimated that the cost to the UK economy of stress, depression and suicide is £26 billion per year. We know that the profession has a high incidence of these problems, so it follows that depressive illness must have an alarming economic effect on it. This means it is essential to invest in improving awareness and support.
"The VBF wants to produce more web videos on issues that veterinary surgeons, students or nurses commonly encounter such as debt, addiction, professional conduct or employment problems. However, we need to secure additional sponsorship in order to fund this work - each 5 minute video will cost about £2,500 to produce. If you or your organization would be interested in supporting this work, please contact the VBF office at 7 Mansfield Street, London W1G 9NQ, telephone 020 7908 6385 or email info@vetlife.org.uk. Donations can also be made online at www.justgiving.com/VBF"
Rory O'Connor, National Co-ordinator at the Veterinary Surgeons' Health Support Programme said: "Many of us will have mental health problems at some point in our lives but most can make a full return to work with the right support. As highlighted in the film, it is really helpful if employers are willing to explore adjustments to working conditions or to the working environment such as flexible working hours or changes to working responsibilities. I am always available to help both employers and employees with these kinds of discussions and we are currently developing content on mental health support in the workplace for the Vetlife website. All advice is completely confidential."
The film was made by John Somers and Ben Sheriff at the University of Exeter using an actress to speak the words of the veterinary surgeon.
Burgess Excel has launched The Excel Food Cube, billed as the first truly 'complete' food for rabbits and guinea pigs, aka 'fibrevores'.
According to the company, it's the first time that rabbit and guinea pig owners will be able to feed a convenient and portion controlled all-in-one food that caters for all of their pets' dental, digestive and emotional needs.
Historically, there has been debate as to whether any one food alone can be classed as 'complete' for these pets. Many foods on the market currently labelled 'complete' only meet the nutritional needs of these pets, because, historically in the world of dog and cat food, that's all a complete food needs to cater for. However, according to Burgess Excel, 72% of vets say that any food labelled as 'complete' for rabbits and guinea pigs should cover dental, digestive and emotional health. To be just 'nutritionally complete' is not enough, because diet accounts for so much more in keeping these pets alive and healthy.
Justin Heaton, Head of Marketing for Burgess Pet Care said "Once again we are incredibly excited and proud to be launching a pioneering new product to the market. Our studies revealed foods labelled 'complete' are generally fed alone, without the hay necessary for fibrevores. As the UK's leading veterinary brand for fibrevores we felt obligated to create a truly healthy, 100% complete food to ensure that pets are being correctly fed. The additional beauty of this product is that it really drives home to fibrevore owners that hay IS food!
The Excel Complete Food Cubes consist of compressed cubes of long fibre Timothy hay for dental and digestive health, together with high fibre tasty nuggets, which contain short fibre, supplements and prebiotics, also necessary for digestive health and to promote foraging. Topped with flowers and beneficial herbs they deliver a visually exciting, innovative solution, inside and out for pet owners."
Justin continued "Excel was the first to expose the myth about 'complete feeds' and identify what the real requirements of these pets are, the first to develop a specific and dedicated feeding plan, the first to identify fibrevores as a subset of small animals and the first to campaign for complete diets to include dental, digestive and emotional health - all of which are why Excel is still the UK's No.1 veterinary recommended food for fibrevores.
However, in today's fast paced and busy world, consumers are always looking for the easiest, least hassle and most convenient ways to feed their pets. To date it has never been easy to find a solution to do this for fibrevores, without compromising their health........ that is until now!"
Burgess says Excel Food Cubes will be available in March but that more information and pre-orders can be taken from your local Burgess representative now. Alternatively, contact Justin Heaton for further information at: Justin.Heaton@burgesspetcare.co.uk
Diverse Undertakings Ltd. has announced that it is extending its services to include support for veterinary practices in securing their RCVS Practice Standards Scheme (PSS) accreditation.
The company was originally formed to provide business advisory services to small and medium sized enterprises across a range of industry sectors. Its services range from general H.R. advice, health & safety guidance and facilities management to candidate sourcing and call-centre services.
However, with previous experience supporting a substantial veterinary practice in Kent for both employment challenges and PSS accreditation, Company Director Neal Palk decided to extend the company's capability to support other veterinary practices in securing their PSS accreditation.
He says that because the needs of each practice vary, Diverse can adapt its service to reflect both the individual circumstances relating to accreditation as well as the capability/capacity with the practice to undertake necessary tasks itself. By using a network of associates, he says Diverse can call upon other specialities (for example - competitively priced office/building equipment) to smooth the progress to accreditation.
Diverse says it offers a range of transparent pricing options to suit the client which, without the overheads of large consultancies, often result in PSS accreditation being achieved for less cost than a typical administrative temp for a month. Monthly retention fee alternatives for other services are available, beginning at £95+ VAT.
Neal said: "Several organisations offer professional services to the veterinary practice sector, but few can claim to have 'been there, done that' and really understand the climate and culture the sector operates within. Diverse Undertakings Ltd. values its experience in the sector and aims to work with other practices to achieve both accreditation and wider business success."
For more details please contact Neal on 07771 843719, e-mail: info@diverseundertakings.com, or visit: http://www/diverseundertakings.com
Pfizer Animal Health and Central Veterinary Services are collaborating in a new venture to create a unified National Benchmarking Database open to all veterinary practices.
In what it says is an unprecedented move, Pfizer will integrate 15 years' worth of data from its Performance Index practice benchmarking service (formerly known as the Fort Dodge Index) with that of the Central Veterinary Services' Management Analysis Indices (MAI). These two benchmarking services have been in co-existence for a number of years, each using different databases. Combining the data from the participating practices within each benchmarking service will create a database of almost 300 practices, representing in excess of 10% of all UK companion animal and mixed practices. This, says the company, will provide a more accurate and relevant benchmarking of UK companion animal practice performance.
The first combined reports from this new National Database will be available in May providing a comprehensive analysis for the first quarter of 2012. For Performance Index practices, this will be available via a new web portal.
Participating practices will continue to access their reports and services independently via their respective portals for PI and MAI, but will benefit from the larger database providing greater accuracy, granularity and relevance of exactly who a practice chooses to benchmark itself against. This, in turn, should provide all participating practices with an even better understanding of both their critical success factors and where there are clear opportunities for growth. Pfizer says that as ever, practice data confidentiality will be guaranteed for all subscribing practices.
Ned Flaxman, Director Business Innovation, at Pfizer Animal Health said: "We have recognised that what veterinary practices really need is to be far more specific about who they benchmark themselves against. There is little relevance to a rural mixed practice in the Lake District employing 3 full time vets (FTVE) benchmarking themselves against a large 5 FTVE companion animal practice in the centre of Manchester - you are comparing apples and pears! My vision for creating the National Database was really to increase the business benefits of practice benchmarking and enable practices to compare apples with apples. With the new system, the large urban practice in Manchester should be able to compare its performance against other urban practices in the North of England employing 5FTVE!
"To ensure practices have accurate and relevant data from which to make informed decisions to grow and thrive in these turbulent conditions, the creation of a single national benchmarking database is the only sensible solution. Although we are effectively levelling the playing field by enabling other veterinary suppliers to offer benchmarking, we believe it is the right thing to do for veterinary practices and the market as a whole. For Pfizer Animal Health, the needs of our veterinary clients are the driving force for our business decisions, veterinary support services and product development."
Martin Barrow, Managing Director of Central Veterinary Services said: "We fully agree that a single benchmarking database is the right solution for the market. The creation of this National Database, open to all practices irrespective of their supplier, will provide the participants with unique tools to give them powerful insights for their practices' future continued success.
"MAI and the Performance Index have competed with each other for years and provided a very useful added value service for their respective subscribers but when we were approached to integrate the two databases, we immediately saw the bigger picture and recognised the significant benefits this could bring to a wider audience of UK veterinary practices.
"The national database uses open standards for data collection and data is accepted from all practices irrespective of which practice management system they use. We believe it is the right thing to do for veterinary practices and brings significant benefits to the whole veterinary profession."
Practices are urged to subscribe to the PI or MAI services either independently or through one of their practice development partners. Although run from a common database each service will continue to be provided with its own unique features.
For further information on Performance Index practices should contact their Pfizer Account Manager, email Pfizer at Vetsupportplusuk@pfizer.com.
For further information on MAI, practices should contact Central Veterinary Services at mai@centralvet.com, or telephone 01359 245310
Researchers at the University of Saskatchewan's Western College of Veterinary Medicine (WCVM) are carrying out a survey of equine practitioners to discover, amongst other things, just how common Cushing's disease is internationally.
The 16-question survey was launched this month and will be available for a further six months at www.wcvm.com/veterinarians/cushings_survey.php
Dr. James Carmalt, an equine surgeon and associate professor in the WCVM's Department of Large Animal Clinical Sciences said: "Our objective is to determine the true prevalence of Cushing's disease worldwide, because until now, previous surveys were only based in the U.S."
Dr. Carmalt is also a PhD student in equine neurophysiology through the western Canadian veterinary college's Department of Veterinary Pathology. He and his graduate supervisor, veterinary pathologist Dr. Andrew Allen, are beginning to explore a new treatment methodology for equine Cushing's disease.
Researchers will use practitioners' responses to the brief survey to determine the incidence of the disease and the most common treatment protocols being used by practitioners in countries around the world. They also want to evaluate the need for developing new treatment methodologies. Dr Carmalt said: "Right now, the only available treatment for Cushing's disease requires daily dosing of medications for the rest of the horse's life. It's onerous, time consuming and a huge management challenge.
"If the responses from this survey reflect our impression that practitioners need a new option to offer their clients, our ultimate goal is to develop a one-time treatment for the disease so daily medications for Cushing's disease become unnecessary."
For more information about the Cushing's disease survey for equine practitioners, please contact Dr. James Carmalt (james.carmalt@usask.ca). As part of the survey, practitioners can also provide their email addresses if they wish to receive a copy of the survey results.
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
Kruuse has launched a new extra large size Bovivet Hoof Bandage for use in the treatment of digital dermatitis (DD) in cattle.
According to the company, an estimated 70 per cent of dairy herds suffer with digital dermatitis and, if not treated, it can persist for months, causing pain and lameness to infected cows. Indeed, a paper1 presented at the BCVA 2011 Congress by Prof. N.B. Cook, Clinical Associate Professor at the School of Veterinary Medicine in Madison, USA, said that "lameness can systematically undermine the management of the dairy herd. No other disease has such fundamental and extensive effects on production, reproduction and risk of early herd removal."
The most effective way to fight DD has been found to be the management and treatment of individual animals. Traditional treatments have involved thoroughly washing the infected hoof, applying an antibiotic/drying agent, such as salicylic acid powder, and then applying a dressing that must remain in place usually for three days. However, it can be hard to correctly dose the salicyclic acid powder and there can be complications in ensuring that the dressing is correctly applied at the right pressure and that it stays in place. It can also be a risk to the user's health when mixing the powder.
Kruuse says this can be made easier by using the Bovivet complete Hoof Bandage along with Kruuse Hoof Gel 38%. Firstly, by using a gel, dosing is easy and more accurate, making it more economical per treatment; and, secondly, for the user, it reduces potential health risks from inhalation of the powder when mixing.
Stuart Wilson from Kruuse UK said: "Since the launch in the UK early last year, the hoof bandage has been very well received by cattle vets, but we were told by them that a larger version was needed in some cases. So Kruuse has produced the new extra large size 'red Jimmy Choos for moos'!"
Kruuse has produced the following instructional video to demonstrate the products' ease of use and versatility, and says that the estimated cost per hoof, assuming ten treatments from a bottle of the gel, is £2.71.
Reference
MSD Animal Health has launched an improved on-farm calf-side scour pathogen testing kit for faster diagnosis of the main infectious organisms implicated in a disease outbreak.
According to the company, the new ScourCheck Rapid Programme promises a 10-minute diagnostic turnaround from faecal sample to result, enabling the veterinary practitioner to offer more timely disease management recommendations without having to wait for a laboratory report. The new kits deliver on-farm identification of rotavirus, coronavirus, cryptosporidium and E. coli K99.
Further details on the ScourCheck Rapid Programme are available from MSD Animal Health account managers.
The British Veterinary Association has reiterated its call for heightened vigilance following confirmation by AHVLA that Schmallenberg virus (SBV) has been detected on four sheep farms in Norfolk, Suffolk and East Sussex.
At this early stage the virus is understood to be vector-borne (although other routes of transmission have not been ruled out) and the clinical signs seen along with meteorological modelling of risk suggests that the four farms were affected during summer/autumn 2011, with congenital defects now becoming visible at lambing time.
Animals imported from the affected areas in northern Europe are also considered to be potentially at risk and their destination in the UK has been identified.
Congenital deformities and nervous defects are seen in newborn lambs, goat kids and calves. Clinical signs in affected cattle include pyrexia (fever), milk drop, and diarrhoea similar to what is often termed 'winter dysentery'. Farmers should be looking out for clusters of these signs within herds and flocks and reporting them to their veterinary surgeon.
Vets who are aware of suspicious clinical signs on their client's farms should report them to AHVLA, SAC or the local DARD divisional veterinary office for further investigation.
AHVLA, SAC and DARD have stated that they are keen to investigate potential cases and there will be no extra charge for the SBV tests that are undertaken, but their approaches are slightly different.
In England, Wales and Northern Ireland AHVLA and AFBI are carrying out SBV-only testing (ie to rule the disease in or out) free of charge but are charging the standard subsidised investigation charge for any additional diagnostic work.
In Scotland any carcases submitted for post mortem examinations are examined at the standard fee and all necessary examinations required by the VIO to investigate the case are included in the fee. SAC is not charging an additional fee for SBV testing.
Carl Padgett, President of the BVA, said: "The confirmation of Schmallenberg virus in sheep flocks in England is a reminder to vets and farmers across the UK to step up vigilance amongst ruminants.
"The BVA would encourage vets to speak to their local AHVLA, SAC or DARD team to discuss any suspect cases and consider submitting specimens for further investigation. We understand that in confirmed cases clinical signs occur in clusters and vets should ensure they know what to look for in both adult and perinatal ruminants.
"While the cases in the south east of England suggest the virus is vector-borne other potential routes of transmission are still being considered. Although the risk of zoonosis is believed to be very low it has not been ruled out and a sensible precautionary approach should be taken by those handling infected animals and specimens."
A new veterinary charity is offering veterinary surgeons, nurses and others in the profession the chance to get fit and raise money for Hounds for Heroes, SPANA and the Pet Blood Bank later this year.
The Vet Charity Challenge (VCC) is looking for teams to take part in a one-day event, involving a series of physical tasks and puzzle-solving challenges along the way, so it requires a bit of brain as well as brawn. The course will feature walking / running, cycling and kayaking and anyone can take part at whatever fitness level.
As well as raising money for the charities, organisers say it will be a fun way to build up camaraderie among your colleagues outside of the work environment and also a local PR opportunity for your practice or business to enhance your community profile.
The event is expecting to raise in excess of £30,000 for charity, but organisers stress that it will need the support of and participation by the veterinary profession to ensure it is a success.
The challenge will take place on Saturday 15th September 2012 at the Royal Agricultural College, Cirencester and all details may be found on http://www.vetcharitychallenge.co.uk/. Alternatively, ring 01727 859259 for further information. The VCC says an early commitment to take part is essential and the fine detail of training can be worked out later. The VCC will provide training guidelines and help you and your team prepare itself.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets 2 and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
Ticks infected with the bacteria that cause Lyme disease may be considerably more prevalent in the UK than recent estimates indicate, according to new research from the University of Bristol that used pet dogs as 'sentinels' for human disease risk.
Transmitted by ticks, Lyme disease is a debilitating chronic infection which affects a number of animals including humans and dogs. It is caused by the bacterium Borrelia burgdorferi. Clinical signs in humans include a characteristic circular red rash that spreads from the site of the tick bite, followed by a flu-like condition. In dogs, the symptoms can be much more vague and difficult to diagnose. If untreated, the disease progresses to neurological problems and arthritis; chronic forms of the disease can last for many years.
While only occasionally affecting humans, reported cases in the UK are thought to have increased more than fourfold since the beginning of the century - from 0.38 per 100,000 in 2000 to 1.79 per 100,000 in 2009. In 2010 there were 953 reported cases in England and Wales but the level of under-reporting is likely to be considerable.
To obtain a clearer picture of the prevalence of infected ticks, Faith Smith of Bristol's School of Biological Sciences and colleagues recruited veterinary surgeons across England, Scotland and Wales to examine dogs selected at random as they visited veterinary practices. Since pet dogs largely share the same environment and visit the same outdoor areas as their owners, exposure to infected ticks in dogs is likely to provide an index for corresponding risks to humans.
Of 3,534 dogs inspected between March and October 2009, 14.9% had ticks. Of the samples that could be tested, 17 (2.3%) were positive for the Borrelia bacteria. The expected prevalence of infected ticks on dogs is 0.5 per cent, or 481 infected ticks per 100,000 dogs. This suggests that the prevalence of Borrelia in the UK tick population is considerably higher than previously thought.
Faith Smith said: "Lyme disease appears to be a rapidly growing problem in the UK with important health and economic impacts in terms of loss of working hours and potential decrease in tourism to tick hotspots.
"Without considerably better surveillance and routine diagnostic testing, Lyme disease is only likely to become more prevalent. In particular, future warmer winters might well extend the period over which ticks are active seasonally, while growing wild reservoir host populations, such as deer, will allow the tick population to expand."
The study is published today in the journal Comparative Immunology, Microbiology and Infectious Diseases. The research was funded by the Natural Environment Research Council (NERC) and Merial Animal Health Ltd.
The RCVS is reminding veterinary surgeons and nurses that there is one week left till the deadline for nominations for the 2012 RCVS and RCVS VN Council elections.
Nominations must be made in writing on the prescribed form and received by the RCVS on or before 31 January 2012.
Prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, manifesto and photograph for inclusion in the RCVS News Extra election specials.
Nobody may nominate more than one candidate, and no current member of the RCVS Council or VN Council may make a nomination.
Full details and guidance notes for both elections are available online from the RCVS Council Election page (www.rcvs.org.uk/rcvscouncil12) and VN Council Election page (www.rcvs.org.uk/vncouncil12).
Nomination forms and candidate information forms for RCVS Council may also be requested from Mrs Gabriella Braun (020 7202 0761 or executiveoffice@rcvs.org.uk) and those for VN Council from Mrs Annette Amato (020 7202 0713 or a.amato@rcvs.org.uk).
Six seats on RCVS Council and two on VN Council are due to be filled in the 2012 elections.
Those elected will take their seats on RCVS Day in July, to serve four-year terms, and will be expected to spend at least six to eight days a year attending Council meetings, working parties and subcommittees (a loss-of-earnings allowance is available).
The RCVS Charitable Trust Library is marking National Libraries Day (4 February) with an open day and prize draws for library users.
The Library is inviting all vets and veterinary nurses - and librarians, staff and students from veterinary schools, other Royal Colleges and university medical schools - to an open day on Friday, 3 February. Free workshops on how to use and search the bibliographic databases will be run by Trust librarians, and those visiting can sign up for a free three-day trial membership. Refreshments will also be provided.
On National Libraries Day, every member of the RCVS Charitable Trust Library will be entered automatically into a draw to win a free 12-month extension to their library membership. Anyone who uses the Trust's Library services between 30 January and 10 February will also be entered into a separate draw for a chance to win a £50 voucher for Trust Library services.
Trust Librarian, Clare Boulton said: "We have an extensive collection of books and online resources useful to vets and VNs, and income from Library members and users helps us to ensure its continuing stewardship. So we're inviting all our users to an open day and holding two prize draws as a way of saying 'thank you'."
The open day will run from 10.30-4pm on Friday, 3 February. Literature search workshops can be booked by contacting Clare Boulton (c.boulton@rcvstrust.org.uk or 020 7202 0752).
Elanco Animal Health has highlighted the results of a new study1 which concludes that Duvaxyn IE-T Plus stimulates a highter protective antibody response than four other equine influenza vaccines commercially available in Ireland.
The trial compared the antibody responses of unvaccinated Thoroughbred weanlings following primary vaccination with Duvaxyn IE-T Plus, Equilis Resequin, Equip FT, Equilis Prequenza Te and ProteqFlu Te.
In addition, following the first vaccination, 43% of the weanlings failed to seroconvert. However, amongst those vaccinated with Duvaxyn IE-T Plus a 100% response rate was observed. The failure rate amongst vaccines other than Duvaxyn IE-T Plus ranged between 7.7% and 78.6%. By the time of the third vaccination (31 weeks after the first) all horses had responded to vaccination.
The study, conducted by the Irish Equine Centre in Johnstone, the Department of Life Sciences at the University of Limerick and the Department of Statistics at Trinity College in Dublin, involved 66 unvaccinated Thoroughbred weanlings on four different stud farms. Following primary vaccination (V1, V2 and V3) with the five vaccines antibody responses were monitored for six months post V3 by single radial haemolysis. Elanco says that the correlation between SRH antibody levels and protection has been well-established and accepted2.
Elanco also highlights a recent study3 which it says demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Richmond/1/07 (H3N8) two weeks after a two dose primary course. The company says that this is believed to be the first demonstration of cross protection by a current UK equine influenza vaccine against a Florida sub-lineage clade 2 reference strain.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "Most studies carried out by vaccine companies take place under controlled conditions that are optimal for effective vaccination. This latest study shows how well Duvaxyn IET plus stimulates immunity under field conditions against both vaccinal and non-vaccinal strains. Importantly, all the weanlings vaccinated with Duvaxyn seroconverted after the first vaccination, conferring earliest and most reliable protection for these vulnerable animals."
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 779881.
References:
Veterinary practices are being urged to raise awareness of summer skin conditions, such as sweet itch, following research carried out by Elanco Companion Animal Health, distributor of Cavalesse, which revealed that vets only tend to be consulted after horse owners have tried to manage the condition themselves (73%), or if the clinical signs have become severe (67%), potentially leading to major welfare implications.
According to the research, this is despite the fact that over half (55%) of owners of a horse with sweet itch showed concern that their horse will suffer, and nearly half being stressed about the way the condition will affect it (47%). While many horse owners are fairly knowledgeable about the causes of sweet itch and its clinical signs, over a quarter of respondents (26%) did not start managing the condition before the midge season in the spring, which may make managing the condition more frustrating. Nearly a third (31%) stated that they had to curtail their activities with their horse due to welfare, aesthetic and behavioural issues, such as head shaking, rubbing, unpredictability and aggression.
Ed Whittle, technical consultant at Elanco Companion Animal Health said: "86% of those questioned considered sweet itch to be a very serious welfare issue if left untreated, with the worst aspects of the condition being the suffering and distress caused by the constant irritation which affects the quality of life of the horse. Over half (55%) felt that sweet itch had adversely affected the behaviour of their horse, making them difficult to handle or ride. Veterinary practices should be proactively talking to their clients about summer skin conditions such as sweet itch to help alleviate the suffering and distress caused by this frustrating disease."
Elanco says it will be joining forces with the British Horse Society (BHS), The Blue Cross, The Horse Trust, Redwings Horse Sanctuary and World Horse Welfare (WHW) to raise awareness of summer skin conditions, such as sweet itch, during Sweet Itch Awareness Month (SIAM) in March. The campaign will highlight the preventative measures that should be carried out to help alleviate sweet itch and the importance of management of the condition before the start of the midge season in the spring.
Lee Hackett, head of welfare at the BHS, said: "The results of this survey show just how important raising awareness of sweet itch is. All of us, whether we are welfare organisations or vets, need to play our part in educating owners about sweet itch in the hope that they will seek expert advice at an earlier stage and reduce the number of horses that suffer as a result of this condition."
Kerry Taylor, education officer at The Blue Cross, said: "The Blue Cross is pleased to be supporting the sweet itch campaign to raise awareness of the physical and mental impact this condition has on horses. During our May 2011 National Equine Health Survey, skin problems came out the top syndrome affecting horses, and we continue to see many horses coming into our care suffering from sweet itch. Prevention and early treatment is key to managing the potentially debilitating condition."
For further information on sweet itch, Sweet Itch Awareness Month or Cavalesse, please visit http://www.fidavet.com/, or contact Elanco Companion Animal Health, Lilly House, Priestley Road, Basingstoke, RG24 9NL, 01256 353131.
Sweet itch - effect on horse and owner. Mo Gannon & Associates. Web survey in November 2011. 351 responses - owners who have owned horses with sweet itch in the last two years.
The Royal Veterinary College has opened a new specialist ophthalmologist service at the Queen Mother Hospital for Animals (QMHA) in Hertfordshire.
According to the College, the service is equipped with the most up-to-date and state-of-the-art equipment available and will also benefit from the on-hand support of leading edge veterinary care at Europe's largest small animal hospital.
The RVC says all ophthalmology cases will be supported by dedicated anesthesiologists, whilst on an individual case basis the ophthalmologists will draw upon the expertise of specialists in imaging, oncology, neurology, emergency and critical care, internal medicine, dermatology, soft tissue and orthopedic surgery.
The following services will be available to all species on referral:
Rick F. Sanchez, who heads up the new service, holds a Diploma from the European College of Veterinary Ophthalmologists (DipECVO) and is currently the only Ophthalmology Diploma holder working in a UK university. In his new role Rick will be sharing his expertise gained from the 3 years intensive specialist training and 7 years in dedicated specialty practice with both undergraduate and postgraduate students at the college in a teaching role alongside his clinical and research responsibilities.
Rick said: "Returning to academia has been the realization of a long held professional dream and to do so by becoming part of the Royal Veterinary College has been a privilege and an honour. The superb team of specialists and dedicated nurses already established at the RVC creates a perfect environment to exercise clinical excellence and offer our animal patients the very best care we strive to provide as specialists.
"In addition, I see the creation of the new Ophthalmology Service as the final piece of the puzzle within the wide array of clinical expertise offered at QMHA. In my opinion it is this wide array of expertise that makes the QMHA at the RVC a leading centre for clinical, teaching and research excellence in veterinary medicine in the UK."
For more information please visit: http://www.rvc.ac.uk/QMH/Specialities/Ophthalmology.cfm
The RCVS Disciplinary Committee has suspended a Co. Tyrone veterinary surgeon from the Register for ten months, having found him guilty of serious professional misconduct relating to three convictions for contravening animal export regulations.
Whilst working as an Authorised Veterinary Inspector in Castlederg for the Department of Agriculture and Rural Development (DARD), William Manson had falsely certified that he had inspected three consignments of sheep presented for assembly at Plumbridge Export Assembly Centre on 16 and 23 August 2009. At this week's two-day hearing, Mr Manson admitted that the convictions he had received at the Strabane Magistrates Court on 26 November 2010 made him unfit to practise veterinary surgery, but said in mitigation that he had examined the sheep nearby at Landahussy, a site he considered more suitable for a large number of animals.
The Committee was satisfied that Mr Manson believed the Landahussy site to be more suitable for large deliveries; the Committee also was satisfied that he did carry out a visual inspection of the sheep at the Landahussy site on 16 and 23 August 2009. However, the information Mr Manson provided on the three certificates was false and misleading. Mr Manson had also been reminded of the importance of complying with government regulations in a disciplinary case in 2004, following convictions for failing to notify DARD about changes in the number of sheep for which he was claiming a premium. The then Committee dismissed the case, deeming the convictions a result of his "genuine but regrettable oversight".
Speaking on behalf of the Committee, Chairman, Prof Peter Lees said: "Mr Manson's actions in certifying that he had examined the sheep at an approved assembly centre when he had not done so amounted to a serious departure from professional standards. If there had been a disease outbreak on either the Plumbridge or Landahussy site, such actions would have rendered contact tracings unreliable and inaccurate."
In mitigation, the Committee accepted medical evidence and Mr Manson's testimony that he was at that time under exceptional stress. He was working long hours in difficult circumstances without an assistant, and was under considerable personal pressure as a result of his wife's serious illness. It also took into account his age (66), exceptional testimonials produced on his behalf, and the impact on the community he served.
Prof Lees said: "The Committee has concluded that the removal of Mr Manson's name from the Register is neither proportionate nor necessary in the public interest nor to protect the welfare of animals. A proportionate sanction in this case is to suspend Mr Manson's name from the Register for a period of ten months."